Good candidates You may be a good candidate for our weight loss program if you identify with any of the following: You are clinically overweight or obese You are struggling to lose weight after childbirth or due to age You have prediabetes You may not be able to safely take weight loss injections if you have a personal or family history of medullary thyroid carcinoma (a type of thyroid cancer), or if you are currently taking certain other medications for diabetes (antidiabetic drugs)
Sudden Hearing Loss (Sudden Sensorineural Hearing Loss)One of the most urgent red flags is tinnitus that comes on suddenly along with a noticeable drop in hearing in one ear
What the tentative approval confirms: The generic product meets FDA standards for safety, quality, and efficacy The application has cleared scientific and regulatory review The only remaining barrier is Novo Nordisk's residual patent protections What it does not mean: The product can be sold or prescribed today in the US Prices will drop immediately Compounded semaglutide remains a legal alternative (it does not see below) The key legal event to watch is patent litigation
Specifically, younger GLP-1RA users (1850 years) exhibited a more pronounced increase in hazard ratios for HZ infections (HR:1.632, 95%CI:1.3631.954) compared to DPP-4i (Additional file 1: Table S8)
Mold in walls, ceilings, HVAC systems, and basements can release spores and mycotoxins continuously into breathing air
Growing demand Despite the lack of robust data, demand for peptides has continued to grow
